• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Psilera

Monday, June 03, 2024
CP
CNS/Neurological
Psilera is a biopharmaceutical company revolutionizing the development of novel serotonergic drugs which provide rapid therapeutic benefit and fewer side effects than conventional treatments. Their world-class scientific and executive team reimagine psychoactive natural products into effective and insurance-backed take-home therapies for psychiatric, addiction, and neurodegenerative disorders. Their proprietary drug discovery engine, Psilera Third Eye, combines novel syntheses of new compounds with an AI-enabled screening platform to design next-generation neurological drugs at the atomic level. By designing next-generation psychedelics without hallucinogenic effects, these drugs have take-home potential with increased patient access. Psilera’s novel drugs aim to be first and best-in-class for a variety of neurological disorders.
Psilera
Company Website: https://www.psilera.com/
Lead Product in Development: PSIL-006 for behavioral variant frontotemporal dementia (bvFTD)

Company HQ City

Tampa

Company HQ State

FL

Company HQ Country

United States

CEO/Top Company Official

Dr. Chris Witowski

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS